Skip to main content
. 2004 Jan;90(1):37–43. doi: 10.1136/heart.90.1.37

Table 1.

Clinical and echocardiographic findings of the study groups

Control (n = 27) HT (n = 25) DM+HT (n = 18) DM (n = 24) p Value
Women 16 15 13 15 NS
Age (years) 50 (10) 55 (8) 54 (11) 51 (10) NS
Smokers 6 5 2 5 NS
PCL (mmol/l) 4.8 (0.69) 6.05 (1.38)* 5.92 (1.78)* 5.33 (1.46) 0.019
Heart rate (beats/min) 75 (9) 78 (12) 80 (12) 78 (10) NS
LVDd (mm) 46 (4) 47 (5) 47 (6) 43 (5) NS
LVSd (mm) 30 (4) 30 (5) 30 (5) 27 (4) NS
EF (%) 64 (7) 68 (9) 67 (7) 67 (8) NS
LAd (mm) 33 (5) 38 (6)* 37 (5)* 35 (4) 0.008
LVMI (g/m2) 84 (21) 111 (37)* 104 (31)* 86 (21)†‡ 0.005
E/A 1.09 (0.24) 0.89 (0.21)* 0.81 (0.17)* 0.80 (0.16)* <0.001
DT (ms) 203 (39) 249 (54)* 242 (42)* 245 (51)* 0.006
IVRT (ms) 85 (18) 124 (23)* 124 (14)* 117 (18)* <0.001

Data are mean (SD) or numbers. Probabilities determined by one way analysis of variance or χ2 test.

DM, diabetic group; DM+HT, diabetic−hypertensive group; DT, mitral early diastolic velocity deceleration time; E/A, ratio of mitral early to late diastolic velocity; EF, left ventricular ejection fraction; HT, hypertensive group; IVRT, left ventricular isovolumetric relaxation time; LAd, left atrial systolic diameter; LVDd, left ventricular diastolic diameter; LVMI, left ventricular mass index; LVSd, left ventricular systolic diameter; NS, not significant (p>0.05); PCL, plasma cholesterol concentration.

*Control group versus patient groups; †HT group versus the other study groups; ‡DM+HT group versus the other study groups.